Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis

NCT02704338 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nanjing Medical University